These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19882152)

  • 1. FDG PET/CT in carcinoma of unknown primary.
    Kwee TC; Basu S; Cheng G; Alavi A
    Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):635-44. PubMed ID: 19882152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of F-18 fluorodeoxyglucose posıtron emıssıon tomography/computed ın carcınoma of unknown primary.
    Elboga U; Kervancioğlu S; Sahin E; Basibuyuk M; Celen YZ; Aktolun C
    Int J Clin Exp Pathol; 2014; 7(12):8941-6. PubMed ID: 25674269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis.
    Kwee TC; Kwee RM
    Eur Radiol; 2009 Mar; 19(3):731-44. PubMed ID: 18925401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of 2-Fluoro-2-Deoxyglucose PET/Computed Tomography in Carcinoma of Unknown Primary.
    Pawaskar AS; Basu S
    PET Clin; 2015 Jul; 10(3):297-310. PubMed ID: 26099668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
    Wu ZJ; Zhang YX; Wei H; Jia Q
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET/CT as a diagnostic tool in patients with extracervical carcinoma of unknown primary site: a literature review.
    Moller AK; Loft A; Berthelsen AK; Damgaard Pedersen K; Graff J; Christensen CB; Perell K; Petersen BL; Daugaard G
    Oncologist; 2011; 16(4):445-51. PubMed ID: 21427201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective comparison of 18F-FDG PET/CT and CT as diagnostic tools to identify the primary tumor site in patients with extracervical carcinoma of unknown primary site.
    Møller AK; Loft A; Berthelsen AK; Pedersen KD; Graff J; Christensen CB; Costa JC; Skovgaard LT; Perell K; Petersen BL; Daugaard G
    Oncologist; 2012; 17(9):1146-54. PubMed ID: 22711751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of survival and evaluation of diagnostic accuracy whole body 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the detection carcinoma of unknown primary origin.
    Tamam MO; Mulazimoglu M; Guveli TK; Tamam C; Eker O; Ozpacaci T
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2120-30. PubMed ID: 23280029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
    Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET and PET/CT for unknown primary tumors.
    Kwee TC; Basu S; Alavi A
    Methods Mol Biol; 2011; 727():317-33. PubMed ID: 21331941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG-PET/CT for detection of the unknown primary head and neck tumor.
    Johansen J; Petersen H; Godballe C; Loft A; Grau C
    Q J Nucl Med Mol Imaging; 2011 Oct; 55(5):500-8. PubMed ID: 22019707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [(18)F-FDG PET-CT in detecting the primary tumor in patients with metastatic cancers of unknown primary origin].
    Hu M; Li MH; Kong L; Liu NB; Yang GR; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):699-701. PubMed ID: 19173915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole body 18F-FDG PET/CT imaging in the detection of primary tumours in patients with a metastatic carcinoma of unknown origin.
    Kaya AO; Coskun U; Unlu M; Akdemir UO; Ozdemir NY; Zengin N; Benekli M; Yildiz R; Yaman E; Ozturk B; Gumus M; Uner A; Yamac D; Ucgul E; Buyukberber S
    Asian Pac J Cancer Prev; 2008; 9(4):683-6. PubMed ID: 19256759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging-prospective study.
    Lee JR; Kim JS; Roh JL; Lee JH; Baek JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2015 Mar; 274(3):764-71. PubMed ID: 25405771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of fluorodeoxyglucose-PET versus fluorodeoxyglucose-PET/computed tomography in detection of unknown primary tumor: a meta-analysis of the literature.
    Dong MJ; Zhao K; Lin XT; Zhao J; Ruan LX; Liu ZF
    Nucl Med Commun; 2008 Sep; 29(9):791-802. PubMed ID: 18677207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the management of patients with carcinoma of unknown primary.
    Deonarine P; Han S; Poon FW; de Wet C
    Scott Med J; 2013 Aug; 58(3):154-62. PubMed ID: 23960054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography as an effective diagnostic workup in cervical metastasis of carcinoma from an unknown primary tumor.
    Zhao K; Luo XM; Zhou SH; Liu JH; Yan SX; Lu ZJ; Yang SY; Lin LL; Dong MJ
    Cancer Biother Radiopharm; 2012 Dec; 27(10):685-93. PubMed ID: 22834634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Importance of nuclear medicine diagnostics in CUP syndrome].
    Winter MC; Haberkorn U; Kratochwil C
    Radiologe; 2014 Feb; 54(2):134-9. PubMed ID: 24445408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.